For: | Couñago F, Luna J, Guerrero LL, Vaquero B, Guillén-Sacoto MC, González-Merino T, Taboada B, Díaz V, Rubio-Viqueira B, Díaz-Gavela AA, Marcos FJ, del Cerro E. Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions. World J Clin Oncol 2019; 10(10): 318-339 [PMID: 31799148 DOI: 10.5306/wjco.v10.i10.318] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v10/i10/318.htm |
Number | Citing Articles |
1 |
David D. Greenberg. CORR Insights®: Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?. Clinical Orthopaedics & Related Research 2020; 478(11): 2458 doi: 10.1097/CORR.0000000000001315
|
2 |
Doo Yong Chung, Dong Hyuk Kang, Hae Do Jung, Joo Yong Lee, Do Kyung Kim, Jee Soo Ha, Jinhyung Jeon, Kang Su Cho. Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis. Investigative and Clinical Urology 2023; 64(3): 242 doi: 10.4111/icu.20230058
|
3 |
Hongfu Sun, Minghao Li, Wei Huang, Jian Zhang, Shihong Wei, Yongjing Yang, Zhongtang Wang, Shucheng Ye, Heyi Gong, Yaowen Zhang, Jie Li, Haixia Song, Lifang Wang, Xiangming Chen, Haiqun Lin, Gaofeng Ding, Hongwei Li, Anping Zheng, Xuezhen Ma, ShaoShui Chen, Liping Liu, Kaixian Zhang, Chengrui Fu, Wenzhi Liu, Jing Wang, Xiaqin Zhang, Tingting Liu, Dan Han, Qian Zhao, Peipei Wu, Qianqian Yuan, LiJun Tian, Ping Zhang, Xueqin Wu, Fei Chen, Zicheng Zhang, Baosheng Li.
Thoracic Radiotherapy Improves the Survival in Patients With
EGFR
-Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial
. Journal of Clinical Oncology 2024; doi: 10.1200/JCO.23.02075
|
4 |
Yi-Hsing Chen, Ue-Cheung Ho, Lu-Ting Kuo. Oligometastatic Disease in Non-Small-Cell Lung Cancer: An Update. Cancers 2022; 14(5): 1350 doi: 10.3390/cancers14051350
|
5 |
Dung-Tsa Chen, Wenyaw Chan, Zachary J. Thompson, Ram Thapa, Amer A. Beg, Andreas N. Saltos, Alberto A. Chiappori, Jhanelle E. Gray, Eric B. Haura, Trevor A. Rose, Ben Creelan, Wei Wang. Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer. PLOS ONE 2021; 16(7): e0252041 doi: 10.1371/journal.pone.0252041
|
6 |
E. Dansin, F. Le Tinier, L. Brouchet, A. Desmet, C. Massabeau, P. Van Houtte, J. Khalifa. Prise en charge des cancers bronchiques non à petites cellules oligométastatiques. Revue des Maladies Respiratoires Actualités 2020; 12(2): 2S94 doi: 10.1016/S1877-1203(20)30090-2
|
7 |
Xabier Mielgo-Rubio, Javier Garde-Noguera, Oscar Juan, Felipe Couñago. Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study. World Journal of Clinical Oncology 2020; 11(12): 983-989 doi: 10.5306/wjco.v11.i12.983
|
8 |
C. Faivre-Finn, N. Venissac, B. Besse, E. Dansin, D. Moro-Sibolot. Prise en charge des cancers bronchiques non à petites cellules oligométastatiques. Revue des Maladies Respiratoires Actualités 2021; 13(2): 2S109 doi: 10.1016/S1877-1203(21)00104-X
|
9 |
Francesca Di Pressa, Fabiana Perrone, Anna Benini, Frank Lohr, Marcello Tiseo, Alessio Bruni. Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach. Exploration of Targeted Anti-tumor Therapy 2024; 5(3): 449 doi: 10.37349/etat.2024.00228
|
10 |
Katsuhiro Hayashi, Hiroyuki Tsuchiya. The role of surgery in the treatment of metastatic bone tumor. International Journal of Clinical Oncology 2022; 27(8): 1238 doi: 10.1007/s10147-022-02144-6
|
11 |
Caleb J. Euhus, Taylor R. Ripley, Cristian G. Medina. The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer. Cancers 2022; 14(10): 2524 doi: 10.3390/cancers14102524
|
12 |
Sankha Bhattacharya. The Incredible Potential of Exosomes as Biomarkers in the Diagnosis of
Colorectal Cancer. Current Drug Research Reviews 2022; 14(3): 188 doi: 10.2174/2665998002666220501164429
|
13 |
Eunji Choi, Sophia J Luo, Jacqueline V Aredo, Leah M Backhus, Lynne R Wilkens, Chloe C Su, Joel W Neal, Loïc Le Marchand, Iona Cheng, Heather A Wakelee, Summer S Han. The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer. JNCI: Journal of the National Cancer Institute 2022; 114(4): 618 doi: 10.1093/jnci/djab224
|
14 |
Abhishek Mahato, Gaurav P.S. Gahlot, Deepak Kumar Jha, Rajhans Rajhans. Inguinal Lymphadenopathy: A Rare Initial Site of Metastatic Lung Carcinoma. World Journal of Nuclear Medicine 2022; 21(04): 334 doi: 10.1055/s-0042-1750397
|
15 |
Huan Ding, Li Shi, Zhuo Chen, Yi Lu, Zhiyu Tian, Hongyu Xiao, Xiaojing Deng, Peiyi Chen, Yue Zhang. Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01341-6
|
16 |
Leilei Wu, Zhenshan Zhang, Menglin Bai, Yujie Yan, Jinming Yu, Yaping Xu. Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientations. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01139-8
|
17 |
Rong Ma, Qian Zhao, Ren Zhao, Juan Li, Yan-Yang Wang. Integrated 18F-FDG PET/CT parameter defines metabolic oligometastatic non-small cell lung cancer. Nuclear Medicine Communications 2022; 43(9): 1026 doi: 10.1097/MNM.0000000000001599
|
18 |
Felipe Renê Alves Oliveira, Allan de Oliveira Santos, Mariana da Cunha Lopes de Lima, Ivan Felizardo Contrera Toro, Thiago Ferreira de Souza, Bárbara Juarez Amorim, Aristoteles Souza Barbeiro, Elba Etchebehere. The ratio between the whole-body and primary tumor burden, measured on 18F-FDG PET/CT studies, as a prognostic indicator in advanced non-small cell lung cancer. Radiologia Brasileira 2021; 54(5): 289 doi: 10.1590/0100-3984.2020.0054
|
19 |
Andrew M. Mendez, Elena N. Petre, Etay Ziv, Fourat Ridouani, Stephen B. Solomon, Vlasios Sotirchos, Ken Zhao, Erica S. Alexander. Safety and efficacy of thermal ablation of adrenal metastases secondary to lung cancer. Surgical Oncology 2024; 55: 102102 doi: 10.1016/j.suronc.2024.102102
|
20 |
Castalia Fernández, Arturo Navarro-Martin, Andrea Bobo, Joaquín Cabrera-Rodriguez, Patricia Calvo, Rodolfo Chicas-Sett, Javier Luna, Nuria Rodríguez de Dios, Felipe Couñago. Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?. World Journal of Clinical Oncology 2022; 13(2): 101-115 doi: 10.5306/wjco.v13.i2.101
|
21 |
Rodolfo Chicas-Sett, Juan Zafra-Martin, Ignacio Morales-Orue, Juan Castilla-Martinez, Miguel A. Berenguer-Frances, Elisa Gonzalez-Rodriguez, Delvys Rodriguez-Abreu, Felipe Couñago. Immunoradiotherapy as an Effective Therapeutic Strategy in Lung Cancer: From Palliative Care to Curative Intent. Cancers 2020; 12(8): 2178 doi: 10.3390/cancers12082178
|
22 |
Kuo Li, Xiaonian Cao, Bo Ai, Han Xiao, Quanfu Huang, Zheng Zhang, Qian Chu, Li Zhang, Xiaofang Dai, Yongde Liao. Salvage surgery following downstaging of advanced non‐small cell lung cancer by targeted therapy. Thoracic Cancer 2021; 12(15): 2161 doi: 10.1111/1759-7714.14044
|
23 |
Satoshi Kato, Satoru Demura, Ryo Kitagawa, Noriaki Yokogawa, Takaki Shimizu, Motoya Kobayashi, Yohei Yamada, Satoshi Nagatani, Hideki Murakami, Norio Kawahara, Hiroyuki Tsuchiya. Clinical outcomes following total en bloc spondylectomy for spinal metastases from lung cancer. Journal of Orthopaedic Science 2024; 29(3): 908 doi: 10.1016/j.jos.2023.04.007
|
24 |
Mónika Blake-Cerda, Francisco Lozano-Ruíz, Federico Maldonado-Magos, Dolores de la Mata-Moya, Diego Díaz-García, Luis Lara-Mejía, Zyanya Lucia Zatarain-Barrón, María-Fernanda Cuevas-Góngora, Feliciano Barron-Barron, José Francisco Corona-Cruz, Luis Cabrera-Miranda, Marisol Arroyo-Hernández, Raquel Gerson, Oscar Arrieta. Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study. Lung Cancer 2021; 152: 119 doi: 10.1016/j.lungcan.2020.12.029
|
25 |
Atallah Baydoun, VeAnn L. Lee, Tithi Biswas. Oligometastatic Non-Small Cell Lung Cancer: A Practical Review of Prospective Trials. Cancers 2022; 14(21): 5339 doi: 10.3390/cancers14215339
|
26 |
Javier Garde-Noguera, Margarita Martín-Martín, Andres Obeso, Miriam López-Mata, Inigo Royo Crespo, Lira Pelari-Mici, O Juan Vidal, Xabier Mielgo-Rubio, Juan Carlos Trujillo-Reyes, Felipe Couñago. Current treatment landscape for oligometastatic non-small cell lung cancer. World Journal of Clinical Oncology 2022; 13(6): 485-495 doi: 10.5306/wjco.v13.i6.485
|
27 |
Lukas Käsmann. Advances in Radiation Oncology in Lung Cancer. Medical Radiology 2022; : 1001 doi: 10.1007/174_2022_339
|
28 |
Çağatay Çetinkaya, Hasan Fevzi Batırel. Airway Diseases. 2023; : 1151 doi: 10.1007/978-3-031-22483-6_65-1
|
29 |
Arsela Prelaj, Chiara Carlotta Pircher, Giacomo Massa, Valentino Martelli, Giulia Corrao, Giuseppe Lo Russo, Claudia Proto, Roberto Ferrara, Giulia Galli, Alessandro De Toma, Carlo Genova, Barbara Alicja Jereczek-Fossa, Filippo de Braud, Marina Chiara Garassino, Sara Elena Rebuzzi. Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression. Cancers 2021; 13(6): 1300 doi: 10.3390/cancers13061300
|
30 |
Jeong Uk Lim. Management of Oligometastasis and Oligoprogression in Patients with Epidermal Growth Factor Receptor Mutation-Positive NSCLC in the Era of Third-Generation Tyrosine Kinase Inhibitors. Clinical Lung Cancer 2021; 22(5): e786 doi: 10.1016/j.cllc.2021.03.004
|
31 |
Satoshi Kato, Satoru Demura, Kazuya Shinmura, Noriaki Yokogawa, Takaki Shimizu, Hideki Murakami, Norio Kawahara, Katsuro Tomita, Hiroyuki Tsuchiya. Surgical Metastasectomy in the Spine: A Review Article. The Oncologist 2021; 26(10): e1833 doi: 10.1002/onco.13840
|
32 |
Hae Lin Cho, Tracy Balboni, Sebastian Matthias Christ, Brandon Turner, Alexander Spektor, Subha Perni. Is Oligometastatic Cancer Curable? A Survey of Oncologist Perspectives, Decision Making, and Communication. Advances in Radiation Oncology 2023; 8(5): 101221 doi: 10.1016/j.adro.2023.101221
|
33 |
Céline Goffinet, H. Marshall, Ian A. Yang, R.V. Bowman, Kwun M. Fong. Encyclopedia of Respiratory Medicine. 2022; : 785 doi: 10.1016/B978-0-08-102723-3.00049-4
|
34 |
François Montagne, Florian Guisier, Nicolas Venissac, Jean-Marc Baste. The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art. Cancers 2021; 13(15): 3711 doi: 10.3390/cancers13153711
|
35 |
Neal Andruska, Hayley B. Stowe, Cathryn Crockett, Wei Liu, David Palma, Corinne Faivre-Finn, Shahed N. Badiyan. Stereotactic Radiation for Lung Cancer: A Practical Approach to Challenging Scenarios. Journal of Thoracic Oncology 2021; 16(7): 1075 doi: 10.1016/j.jtho.2021.04.002
|
36 |
Satoshi Kato, Satoru Demura, Hideki Murakami, Kazuya Shinmura, Noriaki Yokogawa, Ryohei Annen, Motoya Kobayashi, Yohei Yamada, Satoshi Nagatani, Norio Kawahara, Hiroyuki Tsuchiya. Medium to Long-Term Clinical Outcomes of Spinal Metastasectomy. Cancers 2022; 14(12): 2852 doi: 10.3390/cancers14122852
|
37 |
Mihriban Erdoğan, Gönül Demir, Zeliha Güzelöz, Ferhat Eyiler, Cüneyt Ebruli, Olçun Ümit Ünal, Murat Keser, Mustafa Emiroğlu. Radiotherapy in Oligometastatic and Oligoprogressive Disease. The Journal of Tepecik Education and Research Hospital 2023; 33(1): 1 doi: 10.4274/terh.galenos.2021.70487
|